Onofrio Laselva

Assistant Professor at University of Foggia

[Onofrio Laselva @OLaselva]

Olive Leaf Extract (OLE) as a Novel Antioxidant That Ameliorates the Inflammatory Response in Cystic Fibrosis https://t.co/lvkDyeEUl2 #mdpicells via @Cells_MDPI

[Onofrio Laselva @OLaselva]

Our last finding https://t.co/EL8OUEPklR

[Onofrio Laselva @OLaselva]

Our new paper is published! A great collaboration with Dr. Terlizzi at Meyer Children’s Hospital #cysticfibrosis #personalizedmedicine https://t.co/kIERqnDrCl

[Onofrio Laselva @OLaselva]

@eliorossi Thanks Elio! 😁

[Onofrio Laselva @OLaselva]

Excited to share our last finding. A special thanks to my student Maria Laura!
https://t.co/BLaE466ace

[Onofrio Laselva @OLaselva]

Our last protocol to generate Human Pluripotent Stem Cell Derived Lung Models to Measure CFTR Function https://t.co/fLGclR2Xx7

[Onofrio Laselva @OLaselva]

Happy to share our last finding with a great team! Antisense oligonucleotide splicing modulation as a novel Cystic Fibros... https://t.co/AENUYt7Dq6

[Onofrio Laselva @OLaselva]

High-Throughput Functional Analysis of CFTR and Other Apically Localized Proteins in iPSC-Derived Human Intestinal Organoids https://t.co/SC6VNRcAAj #mdpicells via @MDPIOpenAccess

[Onofrio Laselva @OLaselva]

Exited to share our last research on developing cholangiocytes from iPSC for personalized medicine in Cystic Fibrosis https://t.co/rNkuzhySkQ

[Onofrio Laselva @OLaselva]

Exited to share our research on developing a new platform for high-throughput therapy testing for personalized medicine in Cystic Fibrosis https://t.co/4YeXjfFruO

[Journal of Respiration MDPI @JoR_Mdpi]

🟥We congratulate the researchers from the University of Foggia on publishing an excellent review on:

"Three-Dimensional Airway Spheroids and Organoids for Cystic Fibrosis Research"

📜https://t.co/geP4xKteoN
#cysticfibrosis #CF #CFTR #Organoids
@unifg @OLaselva

[Onofrio Laselva @OLaselva]

Three-Dimensional Airway Spheroids and Organoids for Cystic Fibrosis Research https://t.co/jjs3i4DgGM #mdpijor via @MDPIOpenAccess

[Onofrio Laselva @OLaselva]

Our last finding about Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells https://t.co/AegWDtIith

[Onofrio Laselva @OLaselva]

Exited to share our research on developing a photoactivatable probe to identify Ivacaftor binding site to CFTR in biological membranes https://t.co/JJoGjnTTjw

[Onofrio Laselva @OLaselva]

@MMJ_cryoEM Congratulations Mohammad!

[Onofrio Laselva @OLaselva]

Happy to share our last finding about the effect of the recent FDA-approved therapy: TRIKAFTA on rare CFTR mutations. #cysticfibrosis https://t.co/w0QA5L6AEw

[Nicola Lorè @NicolaIvanLore]

Finally published! A new model for studying #lung vicious cycles of #infection and #inflammation, with particular attention on #cysticfibrosis, #haemophilus and #il17 #immunity. Thank you to our co-authors and friends!

@ERSpublications

https://t.co/bZkWN1x71e

[Onofrio Laselva @OLaselva]

@NicolaIvanLore @ERSpublications Congratulations to you and co-authors!

[Onofrio Laselva @OLaselva]

It was exacting to work with biomedical engineers! #Medicinebydesign #universityoftoronto One‐Step Formation of Protein‐Based Tubular Structures for Functional Devices and Tissues https://t.co/lcNfM5Q097

[Prof. Akiko Iwasaki @VirusesImmunity]

This is good. Moderna vaccine also retains neutralizing activity against emerging variants (intact for B.1.1.7 and 6x ⬇️ for B.1.351). Plus, they are now making a new vaccine with B.1.351 spike to test as booster. I bet other vaccine manufacturers are doing the same.